Caplin Point Laboratories Limited has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011.
CAPLIPOINT · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Caplin Point Laboratories has filed a disclosure with the exchange under Regulation 31(4) of the SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011. This is a routine compliance filing typically related to promoter/promoter group shareholding details, including encumbered shares (pledges) or changes in voting rights agreements. The actual details of what changed — such as pledge movements or stake adjustments — are not visible in the headline and would be in the attached disclosure document.
By itself, the filing is a procedural compliance update with no clear indication of a material change. Investors should check the attached Reg 31(4) disclosure to see if promoters created, released, or modified any share pledges, as such moves can affect stock sentiment.